The "TI Pharma Mechanism-Based PKPD Modeling Platform" is a public-private
partnership focused on the development of a mechanism-based PKPD and Systems
Pharmacology models for rational drug discovery and development. After
completion of the successful first phase, the platform is now entering the
second phase of 5 years. "PKPD platform 2.0" comprises of 7 Academic and
Industrial partners and is coordinated by the Leiden Academic Centre for Drug
Research (LACDR) at Leiden University (The Netherlands).
There are now several positions available for postdoctoral fellows. Key
requirements are a strong background in advanced mathematical and statistical
modeling and data analysis (ideally with experience of application in
biomedical sciences), a track record of scientific innovation and a real desire
to be at the forefront of the development of novel concepts in translational
PKPD the emerging discipline of Systems Pharmacology.
For more information, contact
[email protected]<mailto:[email protected]>